GITFIT
PRCT icon

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)’s Procept Biorobotics PRCT Stock Holding History

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.35M Buy
60,000
+10,000
+20% +$250K 0.54% 56
2026
Q1 		$1.25M Hold
50,000
– – 0.65% 54
2025
Q4 		$1.57M Buy
50,000
+24,000
+92% +$796K 0.77% 44
2025
Q3 		$928K Buy
26,000
+7,000
+37% +$320K 0.49% 60
2025
Q2 		$1.09M Buy
19,000
+3,000
+19% +$170K 0.57% 56
2025
Q1 		$932K Buy
+16,000
New +$1.09M 0.59% 55

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s PRCT Position: Q2 2026 in Review

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) increased its Procept Biorobotics (PRCT) stake by 20% in Q2 2026, buying an estimated $250K and bringing the position to 60,000 shares worth $1.35M. The position accounts for 0.54% of the portfolio, ranked #56.

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) first reported a position in PRCT in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.57M in Q4 2025. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) held 60,000 shares of Procept Biorobotics worth $1.35M as of Q2 2026.
  • Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) bought 10,000 Procept Biorobotics shares in Q2 2026, an estimated $250K.
  • Procept Biorobotics made up 0.54% of Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s portfolio in Q2 2026, its #56 holding.
  • Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) first reported a position in Procept Biorobotics in Q1 2025 and has held it in 6 quarters since.
  • Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s Procept Biorobotics position peaked at $1.57M in Q4 2025.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s 13F filing for Q2 2026, filed 22 Jul 2026.